A phase II study of axitinib in advanced neuroendocrine tumors

od Strosberg, J R, Cives, M, Hwang, J, Weber, T, Nickerson, M, Atreya, C E, Venook, A, Kelley, R K, Valone, T, Morse, B, Coppola, D, Bergsland, E K
Izdano u Endocr Relat Cancer (2016)

Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study

od Kelley, R. K., Verslype, C., Cohn, A. L., Yang, T.-S., Su, W.-C., Burris, H., Braiteh, F., Vogelzang, N., Spira, A., Foster, P., Lee, Y., Van Cutsem, E.
Izdano u Ann Oncol (2017)

A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma

od Kelley, R.K., Gane, E., Assenat, E., Siebler, J., Galle, P.R., Merle, P., Hourmand, I.O., Cleverly, A., Zhao, Y., Gueorguieva, I., Lahn, M., Faivre, S., Benhadji, K.A., Giannelli, G.
Izdano u Clin Transl Gastroenterol (2019)

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer

od Kelley, R K, Hwang, J, Magbanua, M J M, Watt, L, Beumer, J H, Christner, S M, Baruchel, S, Wu, B, Fong, L, Yeh, B M, Moore, A P, Ko, A H, Korn, W M, Rajpal, S, Park, J W, Tempero, M A, Venook, A P, Bergsland, E K
Izdano 2013

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates

od Kelley, R. K., Nimeiri, H. S., Munster, P. N., Vergo, M. T., Huang, Y., Li, C.-M., Hwang, J., Mulcahy, M. F., Yeh, B. M., Kuhn, P., Luttgen, M. S., Grabowsky, J. A., Stucky-Marshall, L., Korn, W. M., Ko, A. H., Bergsland, E. K., Benson, A. B., Venook, A. P.
Izdano 2013

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

od Abou-Alfa, G.K., Meyer, T., Cheng, A.-L., El-Khoueiry, A.B., Rimassa, L., Ryoo, B.-Y., Cicin, I., Merle, P., Chen, Y.H., Park, J.-W., Blanc, J.-F., Bolondi, L., Klümpen, H.-J., Chan, S.L., Zagonel, V., Pressiani, T., Ryu, M.-H., Venook, A.P., Hessel, C., Borgman-Hagey, A.E., Schwab, G., Kelley, R.K.
Izdano u N Engl J Med (2018)